Evidence map›Paper›PMID 42410874›Full record

ArticlePsychological medicine2026

Functional connectivity correlates of reaction time variability in treatment-resistant major depression.

Paul Michael Briley, Lucy Webster, Beth Hall, Linda Davison, Peter Gallagher, Stefan Pszczolkowski, Sudheer Lankappa, Dorothee P Auer, Peter F Liddle, R Hamish McAllister-Williams and 1 more

Abstract read
In one paragraph

Article in Psychological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paul Michael BrileyMental Health and Clinical Neurosciences, https://ror.org/01ee9ar58University of Nottingham School of Medicine, UK.ORCID 0000-0002-5372-6505
Lucy Websterhttps://ror.org/04ehjk122Nottinghamshire Healthcare NHS Foundation Trust, UK.ORCID 0000-0003-0424-2587
Beth HallTranslational and Clinical Research Institute, https://ror.org/01kj2bm70Newcastle University, UK.
Linda DavisonTranslational and Clinical Research Institute, https://ror.org/01kj2bm70Newcastle University, UK.
Peter GallagherTranslational and Clinical Research Institute, https://ror.org/01kj2bm70Newcastle University, UK.ORCID 0000-0002-9808-7460
Stefan PszczolkowskiMental Health and Clinical Neurosciences, https://ror.org/01ee9ar58University of Nottingham School of Medicine, UK.ORCID 0000-0002-5859-3190
Sudheer LankappaMental Health and Clinical Neurosciences, https://ror.org/01ee9ar58University of Nottingham School of Medicine, UK.ORCID 0000-0002-2804-7877
Dorothee P AuerMental Health and Clinical Neurosciences, https://ror.org/01ee9ar58University of Nottingham School of Medicine, UK.ORCID 0000-0002-4745-3635
Peter F LiddleMental Health and Clinical Neurosciences, https://ror.org/01ee9ar58University of Nottingham School of Medicine, UK.ORCID 0000-0001-6473-7640
R Hamish McAllister-WilliamsTranslational and Clinical Research Institute, https://ror.org/01kj2bm70Newcastle University, UK.ORCID 0000-0001-9966-1834
Richard MorrissMental Health and Clinical Neurosciences, https://ror.org/01ee9ar58University of Nottingham School of Medicine, UK.ORCID 0000-0003-2910-4121

Funding

Efficacy and Mechanism Evaluation Programme 16/44/02
6 · The paper itself

Abstract

backgroundCognitive difficulties, including problems with attention and executive processing, are common in major depressive disorder (MDD), and strongly predict psychosocial and occupational functioning. Impairment in sustained attention contributes to increased intra-individual variability (IIV) in reaction times observed during cognitive tasks. Understanding brain network changes associated with IIV could guide novel neuromodulation strategies targeting cognitive difficulties.

methodsWe analyzed baseline resting-state fMRI data from 209 patients with moderate-to-severe treatment-resistant MDD who participated in the BRIGhTMIND neuromodulation trial. Following a preregistered analytic protocol, we examined associations between: functional connectivity across three core brain networks (executive control, ECN; default mode, DMN; and salience network, SN); components of IIV derived from a choice reaction time task (using a three-parameter ex-Gaussian model); and functioning.

resultsGreater IIV was linked to increased ECN-DMN functional connectivity. The ECN supports top-down control and externally directed cognition, while the DMN supports internal mentation and rumination. ECN-DMN connectivity was modulated by the SN, which prioritizes salient internal and external stimuli. Higher SN-ECN connectivity was associated with lower ECN-DMN connectivity and with faster mean reaction times. Both IIV and mean reaction time predicted functioning, with poorer functioning related to a slowed and inflexible response pattern.

conclusionsDistinct components of reaction time variability are associated with specific patterns of brain network connectivity, largely independent of mood severity. Connectivity between the salience and executive control networks may represent a promising target for neuromodulation interventions focused on cognitive deficits in MDD.

Indexed as

BrainConnectomeDefault Mode NetworkDepressive Disorder, Treatment-ResistantExecutive FunctionMajor Depressive DisorderNerve NetReaction TimeAdultAttentionFemaleHumansMagnetic Resonance ImagingMaleMiddle Agedbrain connectivitycognitive impairmentdepressionexecutive control network (ECN)functional magnetic resonance imaging (fMRI)intra-individual variabilitymajor depressive disorder (MDD)salience network (SN)social and occupational functioningsustained attention

Identifiers

PMID42410874
PMCPMC13370196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.